Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

Clinical trial NCT06710717 · RECRUITING

Trial details

NCT number: NCT06710717
Sponsor: National University of Malaysia
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematous (SLE)

Start date: 2025-01-03
Primary completion: 2028-12-02
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.